NCT07901751: Study to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT)
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 60 planned
- Started
- Oct 2026
- Primary completion
- Oct 2028
- Arms
- RTx-015 Lower Dose, RTx-015 Higher Dose
- Results
- None posted
- 28 Oct 2026: Trial registered